Determination if oral DCI [INS-1] administration to women with polycystic ovary syndrome increases total DCI content in urine and blood.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs D-chiro-inositol (Primary)
- Indications Polycystic ovary syndrome
- Focus Pharmacokinetics
- 16 Nov 2011 Biomarkers information updated
- 15 Nov 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 Aug 2007 New trial record.